Sort
64,565 grants matching “drug discovery”
Rational Design of High-Affinity Peptide Drug Candidates
$734,769Sriram Shankar · Lynntech, Inc. · R42 · FY2011 · GM
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program
$734,729Primo N Lara · University Of California At Davis · K12 · FY2023 · CA
Antibacterial inhibitors of RnpA
$734,704Paul M. Dunman · University Of Rochester · R01 · FY2021 · AI
Genomic Background of Blood Pressure Response to Thiazide Diuretic in African Americans
$734,693Marguerite R Irvin · University Of Alabama At Birmingham · R01 · FY2016 · HL
Statistical Mechanics with Quantum Potentials: Application to Host-Gues
$734,664Simon Webb · Verachem, Llc · R44 · FY2017 · GM
Statistical Mechanics with Quantum Potentials: Application to Host-Gues
$734,664Simon Webb · Verachem, Llc · R44 · FY2016 · GM
Nicotinic Ligands for Smoking Cessation
$734,650Henry A. Lester · California Institute Of Technology · U19 · FY2013 · DA
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
$734,640David Eric Gerber · Ut Southwestern Medical Center · UG1 · FY2022 · CA
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
$734,640David Eric Gerber · Ut Southwestern Medical Center · UG1 · FY2019 · CA
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
$734,640David Eric Gerber · Ut Southwestern Medical Center · UG1 · FY2020 · CA
Development of linkage-specific ubiquitin binding elements
$734,638James Strickler · Lifesensors, Inc. · R44 · FY2014 · CA
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
$734,482David Albert Schwartz · University Of Colorado Denver · UH3 · FY2025 · HL
Hyperphosphorylated tau aggregation kit to identify tauopathy risk factor
$734,479Maria Ines Morano · Cayman Chemical Company, Inc. · R44 · FY2021 · AG
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$734,389Ticiana Leal · Emory University · UG1 · FY2022 · CA
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
$734,354Christian C Melander · University Of Notre Dame · R01 · FY2024 · AI
Structural variants of Abeta oligomer displacing small molecules
$734,351Susan M Catalano · Cognition Therapeutics, Inc. · R44 · FY2018 · AG
Development of Drugs Acting at Adenosine Receptors
$734,314Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Contribution of Stress Induced Autonomic and Urothelial Dysregulation to IC/BPS
$734,297Lori A Birder · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2015 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2018 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2017 · AI
Norovirus 3CL Protease-Based Anti-norovirus Therapeutics
$734,295Kyeong-Ok Chang · Kansas State University · R01 · FY2016 · AI
Mechanism of parainfluenza virus genome replication
$734,184Rachel Fearns · Boston University Medical Campus · R01 · FY2025 · AI
CAREER: Avoiding Achilles' Heel in Exascale Computing with Distributed File Systems
$734,170Ioan Raicu · Illinois Institute Of Technology · · FY2011 · CSE
Deciphering the role of ddhCTP in viperin-related functions
$734,139Tyler L Grove · Albert Einstein College Of Medicine · R01 · FY2025 · AI